Avexitide | Friends of Cancer Research

You are here

Avexitide

Sponsor: 
Eiger BioPharmaceuticals, Inc.
Indication: 
Post-bariatric hypoglycemia (PBH)
Category: 
Year: 
2019
Date: 
Jun 17th
FDA Status: 
Designation Granted